• US Stocks
  • Biogen Inc.
Biogen Inc.

Biogen Inc.

BIIB
HealthcareLarge Cap 
  • $ 261.22

    Stock Price

  • -$ 4.93(-1.85%)

    Last Change

About the company

Biogen Inc.

Biogen Inc., a biopharmaceutical company, discovers, develops, manufactures, and delivers therapies for the treatment of neurological and autoimmune diseases worldwide. The company offers TECFIDERA, AVONEX, PLEGRIDY, TYSABRI, ZINBRYTA, and FAMPYRA to treat multiple sclerosis (MS); FUMADERM for the treatment of plaque psoriasis; and SPINRAZA to treat spinal muscular atrophy. It also provides BENEPALI, an etanercept biosimilar referencing ENBREL; FLIXABI, an infliximab biosimilar referencing REMICADE; RITUXAN for the treatment of non-Hodgkin's lymphoma, chronic lymphocytic leukemia (CLL), and other conditions; GAZYVA to treat CLL and follicular lymphoma; and other potential anti-CD20 therapies. The company's Phase III clinical trial products comprise GAZYVA for the treatment of front-line indolent non-hodgkin's lymphoma; and Aducanumab and E2609 for Alzheimer's disease. Its Phase II clinical trial products include BIIB074 for trigeminal neuralgia, lumbosacral radiculopathy, and erythromelalgia; BAN2401 for Alzheimer's disease; Opicinumab (anti-LINGO-1) for MS; TYSABRI for acute ischemic stroke; rAAV-XLRS for X-linked juvenile retinoschisis; BG00011 (STX-100) for idiopathic pulmonary fibrosis; and Dapirolizumab pegol and BIIB059 (Anti-BDCA02) for lupus. The company's Phase I clinical trial products comprise BIIB061 for MS; BIIB054 for Parkinson's disease; BIIB067 (IONIS-SOD1Rx) for amyotrophic lateral sclerosis; and BIIB068 (BTK Inhibitor) for autoimmune disease. It has collaboration agreements with AbbVie, Inc.; Acorda Therapeutics, Inc.; Applied Genetic Technologies Corporation; Eisai Co., Ltd.; Genentech, Inc.; Ionis Pharmaceuticals, Inc.; Samsung Bioepis; and University of Pennsylvania. Biogen Inc. offers products through its sales force and marketing groups. The company was formerly known as Biogen Idec Inc. and changed its name to Biogen Inc. in March 2015. Biogen Inc. was founded in 1978 and is headquartered in Cambridge, Massachusetts.
View More
    Total Revenue
    $ 2.509 B
    Cost of Revenue
    $ 469.500 M
    Gross Profit
    $ 2.039 B
    Operating Income
    $ 824.700 M
Scripbox Recommended US Equity Funds
Want to get exposure to US Equity with the ease of Mutual Funds?Learn more

Price chart

$ 267.25

1D High

$ 0.00

1D Low

-$ 4.93 (-1.85%)

1D Change

Last updated on 

Previous Close
$ 266.15
Open Price
$ 266.11
52 Week High
$ 311.88
52 Week Low
$ 187.16
PE Ratio
12.52
Volume
530,462
Avg. Volume
942,920
Market Cap
$ 37.743 B
peers

Peers

Stock NameStock Price52 Week High52 Week LowCapital
Amgen Inc.
Amgen Inc.
$ 236.76$ 292.06$ 219.83Large Cap
$ 143.12$ 162.75$ 128.24Large Cap
$ 155.56$ 181.77$ 151.23Large Cap
$ 45.94$ 51.18$ 40.38Large Cap
$ 343.31$ 509.62$ 339.73Large Cap
$ 73.01$ 86.09$ 69.12Large Cap
$ 48.79$ 56.20$ 36.91Large Cap
$ 128.38$ 248.87$ 127.37Large Cap
$ 32.34$ 53.25$ 31.77Large Cap
peers

Frequently Asked Questions

What is the price of Biogen Inc. share today in India?

Today, on 28th Mar 2024, the price of Biogen Inc. Shares in India is $ 261.22.

What was the highest Biogen Inc. share stock price?

The highest Biogen Inc. stock price was $ 311.88 till 28th Mar 2024 within the past 52 weeks.

What is the lowest price of BIIB shares?

The lowest BIIB stock price was $ 187.16 on 28th Mar 2024 within the past 52 weeks.

How to buy BIIB shares in India?

You can buy BIIB shares in India through Scripbox in just 4 simple steps. The process is simple, seamless, and paperless.
  • Create an account and submit KYC documents
  • On successful KYC, transfer amount required for investment
  • Invest in US stocks
  • Track and manage investments through Scripbox dashboard

Is Biogen Inc. shares Listed on NSE or BSE?

No, BIIB shares are not listed on NSE or BSE. Biogen Inc. is listed on the NASDAQ stock exchange.

Can I buy Biogen Inc. shares in India?

Yes, you can buy Biogen Inc. shares in India by simply opening an account with Scripbox.

Can I buy fractional shares of Biogen Inc.?

Yes, you can buy fractional shares of Biogen Inc. with Scripbox.

What is the P/E ratio for Biogen Inc. shares?

As on 28th Mar 2024, the P/E ratio for Biogen Inc. shares is 12.52.

What is the traded volume of Biogen Inc. shares?

As on 28th Mar 2024, the traded volume for Biogen Inc. shares is 530.462 undefined.

What is the market capitalization of Biogen Inc. shares?

Biogen Inc. shares has a market capitalization of $ 37.743 B.